AEON Biopharma, Inc.
AEON· NYSE
Released Jul 21, 2023, during market hours
10-Q filed Jul 21, 2023, 21 days after period end · 0001104659-23-082959
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|
| Net Income | -$15.38M | $1.87M | -$4.03M |
| EPS Diluted | -$0.11 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
AEON Biopharma, Inc. · CIK 1837607 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Jul 21, 2023 · 21 d after period end